Allarity Therapeutics, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US0167443029

USD

1.08

-0.17 (-13.6%)

Mar 20

NAS

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Plus Therapeutics, Inc.

InMed Pharmaceuticals, Inc.

180 Life Sciences Corp.

Avalo Therapeutics, Inc.

ABVC BioPharma, Inc.

Allarity Therapeutics, Inc.

Dermata Therapeutics, Inc.

Galmed Pharmaceuticals Ltd.

Adial Pharmaceuticals, Inc.

Panbela Therapeutics, Inc.

Baudax Bio, Inc.

Why is Allarity Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Allarity Therapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Allarity Therapeutics, Inc.

26.98%

-0.90

103.65%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

7.12%

EBIT to Interest (avg)

-20.62

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.41

Sales to Capital Employed (avg)

Tax Ratio

1.48%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

9.10%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.71

EV to EBIT

-0.30

EV to EBITDA

-0.30

EV to Capital Employed

-1.45

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-127.49%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at USD -5.13 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at USD -2.52 MM

-2What is not working for the Company

NET PROFIT(Q)

At USD -2.81 MM has Fallen at -47.61%

Here's what is working for Allarity Therapeutics, Inc.

Operating Profit

Highest at USD -2.52 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Allarity Therapeutics, Inc.

Net Profit

At USD -2.81 MM has Fallen at -47.61%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)